​

10x Genomics Ownership | Who Owns 10x Genomics?

OverviewForecastRevenueFinancialsChartTranscripts

10x Genomics Ownership Summary

10x Genomics is owned by 37.74% institutional investors, 1.67% insiders, and 60.59% retail investors. Fmr is the largest institutional shareholder, holding 13.96% of TXG shares. ARK Disruptive Innovation Full Composite is the top mutual fund, with 5.48% of its assets in 10x Genomics shares.

TXG Ownership Benchmark

TypeName% Inst% Insiders% Retail
Stock10x Genomics37.74%1.67%60.59%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryHealthcare Information Services Stocks 33.98%12.11%53.90%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr17.74M13.96%$376.64M
Vanguard group13.02M10.37%$212.32M
Ark investment management11.72M9.22%$248.76M
Blackrock funding, inc. /de10.08M7.93%$214.00M
Blackrock6.39M5.35%$124.34M
Quantinno capital management lp5.41M4.26%$114.89M
Sumitomo mitsui trust5.11M4.02%$108.49M
Nikko asset management americas5.10M4.02%$108.31M
Goldman sachs group3.97M3.13%$84.32M
Geode capital management2.90M2.29%$61.67M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Venrock management vi2.11M100.00%$40.98M
Blue water life science advisors, lp1.09M18.56%$23.14M
Freshford capital management672.96K7.14%$14.29M
Quantedge capital pte416.55K4.84%$8.84M
Tao capital management lp210.86K3.77%$4.48M
Casdin capital2.27M3.66%$48.30M
Sands capital ventures481.77K2.43%$10.23M
Ark investment management11.72M1.93%$248.76M
Exome asset management154.19K1.69%$3.27M
Nikko asset management americas5.10M1.53%$108.31M

Top Buyers

HolderShares% AssetsChange
Fmr17.74M0.02%5.82M
Blue water life science advisors, lp1.09M18.56%1.09M
Balyasny asset management989.52K0.03%989.52K
Goldman sachs group3.97M0.01%884.53K
Casdin capital2.27M3.66%875.00K

Top Sellers

HolderShares% AssetsChange
Generation investment management llp---2.88M
Brown capital management---1.84M
Wellington management group llp---1.45M
Point72 asset management---1.23M
Camber capital management lp---1.00M

New Positions

HolderShares% AssetsChangeValue
Blue water life science advisors, lp1.09M18.56%1.09M$23.14M
Balyasny asset management989.52K0.03%989.52K$21.01M
Vanguard fiduciary trust778.91K0.00%778.91K$16.54M
Meridiem capital partners lp524.00K0.72%524.00K$11.12M
Lord, abbett329.32K0.02%329.32K$6.99M

Sold Out

HolderChange
Strategic advocates-2.00
Key financial-2.00
Concourse financial group securities-3.00
Mather group, llc.-4.00
Northwest investment counselors-6.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026170-48.33%47,954,848-61.12%370.39%83-52.30%52-46.39%
Dec 31, 2025225-30.12%77,554,892-36.98%610.62%120-29.82%63-27.59%
Sep 30, 20252961.72%116,328,6192.84%931.13%157-14.21%8320.29%
Jun 30, 20252997.94%122,334,8068.44%981.17%18519.35%73-1.35%
Mar 31, 2025277-0.72%113,747,6058.46%921.22%1553.33%74-20.43%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
ARK Disruptive Innovation Full Composite7.00M5.48%-684.71K
ARK Innovation ETF6.79M5.26%-495.50K
Vanguard Total Stock Mkt Idx Inv3.76M2.96%11.72K
Vanguard US Total Market Shares ETF3.24M2.65%268.60K
Nikko AM ARK Disruptive Innovation A USD3.14M2.55%126.16K
ARK Genomic Revolution ETF3.23M2.51%136.78K
ARK Genomic Revolution3.05M2.39%-102.59K
Amova ARK Disruptive Innovation A USD2.83M2.20%-28.93K
Vanguard Small Cap Index2.71M2.13%-10.48K
iShares Russell 2000 ETF2.65M2.05%22.32K

Recent Insider Transactions

DateNameRoleActivityValue
May 26, 2026Saxonov Serge Chief Executive OfficerSell$264.83K
May 22, 2026Saxonov Serge Chief Executive OfficerSell$444.22K
May 22, 2026Hindson Benjamin J. See RemarksSell$283.40K
May 22, 2026Taich Adam Chief Financial OfficerSell$369.02K
Apr 14, 2026Saxonov Serge Chief Executive OfficerSell$122.78K

Insider Transactions Trends

DateBuySell
2026 Q2-5
2026 Q1-8
2025 Q4-3
2025 Q3-3
2025 Q2-3

TXG Ownership FAQ

Who Owns 10x Genomics?

10x Genomics shareholders are primarily institutional investors at 37.74%, followed by 1.67% insiders and 60.59% retail investors. The average institutional ownership in 10x Genomics's industry, Healthcare Information Services Stocks , is 33.98%, which 10x Genomics exceeds.

Who owns the most shares of 10x Genomics?

10x Genomics’s largest shareholders are Fmr (17.74M shares, 13.96%), Vanguard group (13.02M shares, 10.37%), and Ark investment management (11.72M shares, 9.22%). Together, they hold 33.55% of 10x Genomics’s total shares outstanding.

Does Blackrock own 10x Genomics?

Yes, BlackRock owns 5.35% of 10x Genomics, totaling 6.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 124.34M$. In the last quarter, BlackRock increased its holdings by 385.01K shares, a 6.41% change.

Who is 10x Genomics’s biggest shareholder by percentage of total assets invested?

Venrock management vi is 10x Genomics’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 2.11M 10x Genomics shares, valued at 40.98M$.

Who is the top mutual fund holder of 10x Genomics shares?

ARK Disruptive Innovation Full Composite is the top mutual fund holder of 10x Genomics shares, with 5.48% of its total shares outstanding invested in 7M 10x Genomics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools